skip to Main Content

The AIM-HI Accelerator Fund is pleased to be presenting the inaugural Women’s Venture Competition, in which all selected finalists will have the opportunity to benefit from intensive accelerator boot-camp programming by one of the world’s most renowned women entrepreneur accelerator and business training service providers, Springboard Enterprises, and—subject to due diligence and negotiation—the winning business will receive up to $300,000 in AIM-HI investment.

When:
Wednesday, May 20, 2020

Where:
Joseph B. Martin Conference Center at Harvard Medical School
Room 214
77 Avenue Louis Pasteur
Boston, Massachusetts

Joseph B. Martin Conference Center at Harvard Medical School Logo

Download Flier

Judging Committee:

Barbara Webber, M.D., Co-Chair

Barbara Webber, M.D., Co-Chair

President & CEO, Tango Therapeutics

Raju Kucherlapati, Ph.D., Co-Chair

Raju Kucherlapati, Ph.D., Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Joan Brugge, Ph.D.

Joan Brugge, Ph.D.

Louise Foote Pfeiffer Professor of Cell Biology & Director of Ludwig Center, Harvard Medical School

Webster Cavenee, Ph.D.

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Pamela Garzone, Ph.D.

Pamela Garzone, Ph.D.

Chief Medical Officer, Calibr at Scripps Research

Tom Miller

Tom Miller

Founder & Managing Partner, GreyBird Ventures

Amy Millman

Amy Millman

President & Co-Founder, Springboard Enterprises

Robert Tepper, M.D.

Robert Tepper, M.D.

Partner, Third Rock Ventures

Partner Organizations:

NFCR-logo
Springboard+Logo
AFCR-logo

Sponsor Organizations:

DSW
BLA

Overview:

Each applicant must meet eligibility criteria and submit an online application consisting of summary details, a short video and a presentation summarizing her business plan.

Applicants, all female, will be screened by a selection committee, and finalists chosen are invited to pitch to a judging committee on the day of the Women’s Venture Competition. At the conclusion of the event, the two highest rated companies or venture teams among the finalists will be named and recognized—with cash awards of $3,000 granted to the winner and $2,000 granted to the runner-up.

Over the subsequent few weeks, the AIM-HI Accelerator Fund will perform detailed due diligence on and communicate with these, the top two Women’s Venture Competition finalists, in order to determine allocation of up to $300,000 in AIM-HI investment into the business deemed to have the stronger potential for return and cancer patient impact.

Eligibility:

  • Application must be submitted by a woman in senior leadership of an oncology start-up company with equity stakes—could be a founder, president, chief executive officer, chief scientific officer or chief medical officer—or a woman leading a venture team planning to set up such a company in the near future.
  • Applicant and her company or venture team must demonstrate track record of milestone achievement, such as, but not necessarily limited to, government or foundation grants, patents, successful clinical trial phases, commercial exits, etc.
  • No fee to apply, but each of the selected finalists must put forward a $250 entrance payment in order to participate in the Women’s Venture Competition.

Timeline & Format:

  • Application Deadline: Thursday, April 16, 2020, 5:00 PM ET; Online application 
  • Announcement of Finalists: On or around Wednesday, May 6, 2020; E-mail communication to all approved applicants, online to general public
  • Springboard Enterprises’ Accelerator Bootcamp: Health Innovation Hub—Life Science: Tuesday, May 12 through Thursday, May 14, 2020; Observer status of highly valuable Boston programming
  • Women’s Venture Competition: Wednesday, May 20, 2020; Boston event
  • Announcement of Investment: By Summer 2020; In person, e-mail or telephone communication to the selected finalist, online to general public

Women’s Venture Competition Format:

A series of private, confidential presentations by the women applicant submitters or individually designated female colleagues of oncology start-up company or venture teams.

PowerPoint or similar presentation formats are required, and must be delivered—verbally and visually—in English. Presenters are to be on-site well in advance of their predesignated time slot, and abide by the to-be-determined time limit (depending on the number of finalists, this will range from a minimum of 30 minutes to a maximum of 45 minutes, including segue and the judging committee feedback and questioning periods), which will be strictly enforced per presentation.

After the conclusion of the event, at an evening reception and award dinner, the two highest rated companies or venture teams among the finalists will be highlighted, and cash awards of $3,000 and $2,000 granted to the winner and runner-up, respectively. All finalist presenters are required to reconvene and be present for the reception and award dinner, at which group photographs will also be taken.

Over the following few weeks, the AIM-HI Accelerator Fund will perform detailed due diligence on and communicate with these, the top two Women’s Venture Competition finalists, in order to determine allocation of up to $300,000 in AIM-HI investment into the business deemed to have the stronger potential for return and cancer patient impact.

Disclaimers:

  • Women’s Venture Competition applicants need not yet be with structured businesses at the time of their application submission, nor even the event itself, as women-led venture teams planning to set up such a company in the near future are eligible and encouraged to participate. However, the AIM-HI Accelerator Fund’s investment of up to $300,000 will only be made into a formally established and operating legal, for-profit entity into which it garners equity.
  • Neither of the two highest rated finalists as determined by the Women’s Venture Competition are guaranteed up to $300,000 in investment by the AIM-HI Venture Fund. Any capital allocation will be determined by the organization’s ensuing due diligence and is contingent upon mutually agreed conditions and terms.

If you have questions, need more information or are interested in sponsoring this or other AIM-HI Accelerator Fund initiatives, please contact:

Bradley Gillenwater
Senior Director
bgillenwater@aim-hiaccelerator.org

Back To Top